Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2325 of 3284 entries
View as:

Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage

Phase: N/A Priority: Normal
NCT ID: NCT01275794 Org: User:
Start: 12/31/10 End: 03/31/11 Due: 03/31/12

Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01150812 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Second Line Breast Cancer Trial

Phase: N/A Priority: Normal
NCT ID: NCT00635713 Org: User:
Start: 05/31/97 End: 09/30/04 Due: 09/30/05

Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.

Phase: N/A Priority: Normal
NCT ID: NCT02052635 Org: User:
Start: 09/30/14 End: 04/30/15 Due: 04/30/16

Type 2 Diabetes Mellitus Patients' Characteristics and Management by General Practitioners and Endocrinologists

Phase: N/A Priority: Normal
NCT ID: NCT03209089 Org: User:
Start: 08/07/17 End: 04/15/19 Due: 04/15/20

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00075192 Org: User:
Start: 03/31/04 End: 03/31/06 Due: 03/31/07

Treatment Clinical Practice in Bipolar Depression in Spain

Phase: N/A Priority: Normal
NCT ID: NCT00757328 Org: User:
Start: 07/31/08 End: 12/31/08 Due: 12/31/09

Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01006603 Org: User:
Start: 10/31/09 End: 06/30/12 Due: 06/30/13

Antidepressant Incomplete Response Depression

Phase: N/A Priority: Normal
NCT ID: NCT00782964 Org: User:
Start: 10/31/08 End: 11/30/09 Due: 11/30/10

Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00435760 Org: User:
Start: 02/28/07 End: 08/31/07 Due: 08/31/08

The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China

Phase: N/A Priority: Normal
NCT ID: NCT01785901 Org: User:
Start: 05/31/13 End: 10/31/14 Due: 10/31/15

Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00230516 Org: User:
Start: 09/30/05 End: 02/28/06 Due: 02/28/07

A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03106987 Org: User:
Start: 06/08/17 End: 02/17/22 Due: 02/17/23

A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT01214122 Org: User:
Start: 11/30/10 End: 12/31/10 Due: 12/31/11

Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01569074 Org: User:
Start: 04/30/12 End: 07/31/13 Due: 07/31/14

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day

Phase: N/A Priority: Normal
NCT ID: NCT01360021 Org: User:
Start: 11/30/11 End: 08/31/12 Due: 08/31/13

Pharmacokinetic Interaction Between AZD3480 and Donepezil

Phase: N/A Priority: Normal
NCT ID: NCT00713765 Org: User:
Start: 12/31/08 End: 12/31/08 Due: 12/31/09

An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03457220 Org: User:
Start: 06/21/18 End: 12/31/19 Due: 12/31/20

Tezepelumab Phase 1 PK Study in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04362410 Org: User:
Start: 05/18/20 End: 10/09/20 Due: 10/09/21

Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118

Phase: N/A Priority: Normal
NCT ID: NCT01520896 Org: User:
Start: 02/29/12 End: 04/30/12 Due: 04/30/13

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02032823 Org: User:
Start: 04/22/14 End: 05/28/29 Due: 05/28/30

Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06673043 Org: User:
Start: 02/28/25 End: 06/30/28 Due: 06/30/29

A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)

Phase: N/A Priority: Normal
NCT ID: NCT05460273 Org: User:
Start: 07/11/22 End: 12/31/25 Due: 12/31/26

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01966107 Org: User:
Start: 10/16/13 End: 09/21/17 Due: 09/21/18

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Phase: N/A Priority: Normal
NCT ID: NCT00641056 Org: User:
Start: 04/30/08 End: 11/30/09 Due: 11/30/10